Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective study.

Suda G, Ohara M, Baba M, Yamamoto Y, Yoshida S, Fu Q, Yang Z, Hosono H, Yokoyama D, Kitano S, Tanaka T, Meno A, Yasuura N, Kitagataya T, Kawagishi N, Nakai M, Sho T, Ogawa K, Maehara O, Ohnishi S, Izumi T, Yamada R, Meguro T, Terashita K, Takagi T, Ito J, Kobayashi T, Tsunematsu I, Sakamoto N

Open source

DOI: 10.1016/j.jinf.2026.106715
Published: 2026 Apr
Container: The Journal of infection
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jinf.2026.106715,
  title = {Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective study.},
  author = {Suda G and Ohara M and Baba M and Yamamoto Y and Yoshida S and Fu Q and Yang Z and Hosono H and Yokoyama D and Kitano S and Tanaka T and Meno A and Yasuura N and Kitagataya T and Kawagishi N and Nakai M and Sho T and Ogawa K and Maehara O and Ohnishi S and Izumi T and Yamada R and Meguro T and Terashita K and Takagi T and Ito J and Kobayashi T and Tsunematsu I and Sakamoto N},
  year = {2026},
  journal = {The Journal of infection},
  doi = {10.1016/j.jinf.2026.106715},
  url = {https://doi.org/10.1016/j.jinf.2026.106715}
}

RIS

TY  - JOUR
TI  - Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective study.
AU  - Suda G
AU  - Ohara M
AU  - Baba M
AU  - Yamamoto Y
AU  - Yoshida S
AU  - Fu Q
AU  - Yang Z
AU  - Hosono H
AU  - Yokoyama D
AU  - Kitano S
AU  - Tanaka T
AU  - Meno A
AU  - Yasuura N
AU  - Kitagataya T
AU  - Kawagishi N
AU  - Nakai M
AU  - Sho T
AU  - Ogawa K
AU  - Maehara O
AU  - Ohnishi S
AU  - Izumi T
AU  - Yamada R
AU  - Meguro T
AU  - Terashita K
AU  - Takagi T
AU  - Ito J
AU  - Kobayashi T
AU  - Tsunematsu I
AU  - Sakamoto N
PY  - 2026
JO  - The Journal of infection
DO  - 10.1016/j.jinf.2026.106715
UR  - https://doi.org/10.1016/j.jinf.2026.106715
ER  -

APA

G, S., M, O., M, B., Y, Y., S, Y., Q, F., Z, Y., H, H., D, Y., S, K., T, T., A, M., N, Y., T, K., N, K., M, N., T, S., K, O., O, M., S, O., T, I., R, Y., T, M., K, T., T, T., J, I., T, K., I, T., & N, S. (2026). Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective study.. The Journal of infection. https://doi.org/10.1016/j.jinf.2026.106715

Source records

pubmed · retrieved 2026-09-27T15:33:31.764Z